GRR - Global Regional Review

A STUDY OF AWARENESS AND KNOWLEDGE ABOUT EPIDERMODYSPLASIA VERRUCIFORMISA GENETIC DISORDER

http://dx.doi.org/10.31703/grr.2021(VI-I).12 10.31703/grr.2021(VI-I).12
Authored by : Tania Naveel , Sidra Afzal , Mahira Afzal

12 Pages : 105-111

References

Androphy, EJ. Dvoretzky, I. Lowy, DR. (1985). Xlinked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 121(7):864-868.
Cougoul, P., et al.,(2015). Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine. Annals of hematology, 94(6): p. 1071-1073.
De Jong, S.J., et al., (2018b) The human CIB1- EVER1-EVER2 complex governs keratinocyteintrinsic immunity to ÃŽÂ²-papillomavirusesCIB1 deficiency in epidermodysplasia verruciformis. The Journal of experimental medicine, 215(9): p. 2289-2310.
De Jong, S.J., et al.,(2018a). Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses. Frontiers in microbiology, 9: p. 1222.
De Oliveira, W.R., et al., (2015). Deleterious effect of radiation therapy on epidermodysplasia verruciformis patients. Journal of Cutaneous Medicine and Surgery,19(4): p. 416-421.
Genetics. 32(4):579-81.doi:10.1038/ng1044. PMID 12426567. https://doi. org/10.1038/ng1044.
GÃƒÂ¼l, ÃƒÂœ., et al., (2007). Clinical aspects of epidermodysplasia verruciformis and review of the literature. International journal of dermatology, 46(10): p. 1069-1072.
Hague, J.E., & Crosby, E.L. (1948). Television Newest Aid in Teaching Surgery, Mod Hosp 70:65-67 (April).
Harris, J.J. (1966). Television as an Educational Medium in Medicine: An Historical Purview, J Med Educ 41:1-19 (Jan).
Kim, C., et al., (2016). Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate. Journal of drugs in dermatology: JDD, 15(3): p. 350.
Lazarczyk, M. Pons, C. Mendoza, JA. Cassonnet, P. Jacob, Y. & Favre, M. (2008).
Lutzner, MA. (1978). Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer. 65(2):169-182.
Myers, D.J. & Fillman, E.P. (2019). Epidermodysplasia verruciformis, in StatPearls [Internet]. 2019, StatPearls Publishing
Orth, G. (1986). Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp. 120:157-174.
Przybyszewska, J., A. Zlotogorski, & Y. Ramot, (2017). Re-evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate. Journal of the American Academy of Dermatology, 76(6): p. 1161-1175.
Ramoz, N. Rueda, LA. Bouadjar, B. Montoya, LS. Orth, G. & Favre M. (2002).
Sehgal VN, Luthra A, Bajaj P. (2002). Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol. 41(8):500-503.
Sun, XK. Chen, JF. & Xu, AE. (2005). A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol. 30(5):573-
Zavattaro, E. Azzimonti, B. Mondini, M. et al. (2008). Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol. 128 (3):732- 5.

References

Androphy, EJ. Dvoretzky, I. Lowy, DR. (1985). Xlinked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 121(7):864-868.
Cougoul, P., et al.,(2015). Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine. Annals of hematology, 94(6): p. 1071-1073.
De Jong, S.J., et al., (2018b) The human CIB1- EVER1-EVER2 complex governs keratinocyteintrinsic immunity to ÃŽÂ²-papillomavirusesCIB1 deficiency in epidermodysplasia verruciformis. The Journal of experimental medicine, 215(9): p. 2289-2310.
De Jong, S.J., et al.,(2018a). Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses. Frontiers in microbiology, 9: p. 1222.
De Oliveira, W.R., et al., (2015). Deleterious effect of radiation therapy on epidermodysplasia verruciformis patients. Journal of Cutaneous Medicine and Surgery,19(4): p. 416-421.
Genetics. 32(4):579-81.doi:10.1038/ng1044. PMID 12426567. https://doi. org/10.1038/ng1044.
GÃƒÂ¼l, ÃƒÂœ., et al., (2007). Clinical aspects of epidermodysplasia verruciformis and review of the literature. International journal of dermatology, 46(10): p. 1069-1072.
Hague, J.E., & Crosby, E.L. (1948). Television Newest Aid in Teaching Surgery, Mod Hosp 70:65-67 (April).
Harris, J.J. (1966). Television as an Educational Medium in Medicine: An Historical Purview, J Med Educ 41:1-19 (Jan).
Kim, C., et al., (2016). Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate. Journal of drugs in dermatology: JDD, 15(3): p. 350.
Lazarczyk, M. Pons, C. Mendoza, JA. Cassonnet, P. Jacob, Y. & Favre, M. (2008).
Lutzner, MA. (1978). Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer. 65(2):169-182.
Myers, D.J. & Fillman, E.P. (2019). Epidermodysplasia verruciformis, in StatPearls [Internet]. 2019, StatPearls Publishing
Orth, G. (1986). Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp. 120:157-174.
Przybyszewska, J., A. Zlotogorski, & Y. Ramot, (2017). Re-evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate. Journal of the American Academy of Dermatology, 76(6): p. 1161-1175.
Ramoz, N. Rueda, LA. Bouadjar, B. Montoya, LS. Orth, G. & Favre M. (2002).
Sehgal VN, Luthra A, Bajaj P. (2002). Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol. 41(8):500-503.
Sun, XK. Chen, JF. & Xu, AE. (2005). A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol. 30(5):573-
Zavattaro, E. Azzimonti, B. Mondini, M. et al. (2008). Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol. 128 (3):732- 5.